Heather McArthur, MD of Cedars-Sinai Medical Center discusses a Phase 1 Study that was being presented at ASCO-SITC. This study combines Carboplatin, Paclitaxel, and an HPV vaccine in the therapeutic setting. She states that even though it is a provocative and early study, the data shows great promise. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Carboplatin + Paclitaxel + HPV Vaccine Shows Dramatic Response
